1 year return (CAGR)
253.96%
Apogee Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
APGE
135.07
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
79.13%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
8.40B
Price/Sales
-
Ent value
8.44B
Price/Book
7.03
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 135.07 |
| Daily high | 135.07 |
| Daily low | 135.07 |
| Daily Volume | 0K |
| All-time high | 135.08 |
| 1y analyst estimate | 134.85 |
| Beta | 0.34 |
| EPS (TTM) | -3.90 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 10 Mar 2026 |
Downside potential
Loading...
Downside potential data
| APGE | S&P500 | |
| Current price drop from All-time high | -0.01% | -0.61% |
| Highest price drop | -58.75% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -22.51% | -10.68% |
| Avg time to new high | 11 days | 12 days |
| Max time to new high | 428 days | 1805 days |
News
No items found